Innate Pharma S.A.
IPHYF News Today: Stay Updated with the Latest Innate Pharma S.A. News in Real Time
Find IPHYF news now at Meyka AI. Stay informed with the latest Innate Pharma S.A. stocks updates, including price news, market analysis, and expert insights.
Pre-market top loser: IPH.PA Innate Pharma β¬1.15 on 21 Mar 2026: earnings risk ahead
IPH.PA stock falls to β¬1.15 pre-market on 21 Mar 2026; analysis, grade, and Meyka AI forecast for near-term downside and catalysts
0503.HK Lansen Pharma (HKSE) up 40.94% pre-market 21 Mar 2026: Watch volume
0503.HK stock jumps 40.94% pre-market on heavy volume; our analysis covers drivers, metrics and a Meyka AI forecast
India-Canada Ties March 21: RCMP Finds No Proof of Transnational Repression
India Canada relations: RCMP statement finds no proof of transnational repression links to India. What this means for trade, energy, and investment flows for Indian investors on March 21.
Pre-Market Top Gainer 21 Mar 2026: Stella Pharma (4888.T) JPX +8.04% ahead of 646.00 JPY test
4888.T stock jumps pre-market to JPY 605.00 on heavy volume; analysis, Meyka grade and forecast
IGPH.SW IGEA Pharma (SIX) -25% pre-market 20 Mar 2026: volume spike, volatility likely
Pre-market IGPH.SW stock update: **CHF 0.0015**, -25.0% and heavy volume on SIX; quick valuation and forecast
47.16M intraday, 4597.T Solasia Pharma (JPX) Mar 2026: most active, watch catalysts
Intraday: 4597.T stock at JPY 32.00 with 47.16M volume on JPX; grade, forecast and catalysts
^GSPC Today, March 19: Fed Holds; SEP Lifts GDP, Core PCE to 2.7%
FOMC rate decision: Fed holds 3.5%-3.75%; SEP lifts US GDP 2.4% and core PCE 2.7%. See how this shapes ^GSPC, USD/INR, and Indian portfolios today.
Sangamo Therapeutics (SGMO) NASDAQ US 18 Mar 2026: Market closed, earnings tonight
SGMO stock earnings preview for 18 Mar 2026; price $0.36, catalysts and Meyka AI forecast for investors
MSFT Stock Today: March 18 β Pharma Blockchain Spend Set to Surge
MSFT and Germany: blockchain in pharmaceutical δΎ demand rises as supply chains digitize. Market seen at $6.57B by 2033. What it means for Azure growth, traceability, and anti counterfeit drugs.